Authors: fang, x.; liu, s.; wang, x-y.¹; gao, n.¹; hu, h-z.¹; wang, g-d.¹; cook, c. h.²; needleman, b. j.²; mikami, d. j.²; xia, y.; fei, g-j.¹; hicks, g. a.³; wood, j. d.¹

Source: Neurogastroenterology and Motility, Volume 20, Number 1, January 2008 , pp. 80-93(14)

Publisher: Wiley-Blackwell

Abstract:

 

Actions of the 5-HT₄ serotonergic receptor partial agonist, tegaserod, were investigated on mucosal secretion in the guinea-pig and human small intestine and on electrophysiological behaviour of secretomotor neurons in the guinea-pig small intestinal submucosal plexus. Expression of 5-HT₄ receptor protein and immunohistochemical localization of the 5-HT₄ receptor in the submucosal plexus in relation to expression and localization of choline acetyltransferase and the vesicular acetylcholine (ACh) transporter were determined for the enteric nervous system of human and guinea-pig small intestine. Immunoreactivity for the 5-HT₄ receptor was expressed as ring-like fluorescence surrounding the perimeter of the neuronal cell bodies and co-localized with the vesicular ACh transporter. Exposure of mucosal/submucosal preparations to tegaserod in Ussing chambers evoked increases in mucosal secretion reflected by stimulation of short-circuit current. Stimulation of secretion had a relative high EC₅₀ of 28.1 ± 1.3 μmol L⁻¹, was resistant to neural blockade and appeared to be a direct action on the secretory epithelium. Tegaserod acted at presynaptic 5-HT₄ receptors to facilitate the release of ACh at nicotinic synapses on secretomotor neurons in the submucosal plexus. The 5-HT_2B receptor subtype was not involved in actions at nicotinic synapses or stimulation of secretion.

Keywords: 5-HT4 serotonergic receptors; enteric nervous system; intestine; secretion

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2982.2007.00983.x

Affiliations: 1: Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA 2: Department of Surgery, College of Medicine, The Ohio State University, Columbus, OH, USA 3: Novartis Pharmaceuticals Corp., East Hanover, NJ, USA

Publication date: 2008-01-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Gastroenterology
• By this author: fang, x. ;  liu, s. ;  wang, x-y. ;  gao, n. ;  hu, h-z. ;  wang, g-d. ;  cook, c. h. ;  needleman, b. j. ;  mikami, d. j. ;  xia, y. ;  fei, g-j. ;  hicks, g. a. ;  wood, j. d.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers